REPLIGEN CORP (RGEN) › Operating IncomeREPLIGEN CORP (RGEN) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2010: -$5.77M2011: -$374.1K2012: $11.08M2013: $22.87M2014: $10.69M2015: $13.76M2016: $15.97M2017: $14.01M2018: $25.99M2019: $36.08M2020: $69.82M2021: $167.25M2022: $224.67M2023: $47.70M2024: -$35.11M2025: $55.17M$55.17M2010Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$55.17M+257.1%2024-$35.11M-173.6%2023$47.70M-78.8%2022$224.67M+34.3%2021$167.25M+139.5%2020$69.82M+93.5%2019$36.08M+38.8%2018$25.99M+85.6%2017$14.01M-12.3%2016$15.97M+16.1%2015$13.76M+28.7%2014$10.69M-53.3%2013$22.87M+106.4%2012$11.08M+3062.8%2011-$374.1K+93.5%2010-$5.77M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share